|Year : 2019 | Volume
| Issue : 3 | Page : 110-122
The influence of one-carbon metabolism gene polymorphisms and gene-environment interactions on homocysteine, Vitamin B12, folate and lipids in a Brazilian adolescent population
Shelini Surendran1, Carla C Morais2, Dulcinéia S P Abdalla3, Israa A Shatwan1, Julie A Lovegrove4, Cristiane Cominetti2, Vimaleswaran Karani Santhanakrishnan1, Maria A Horst3
1 Department of Food and Nutritional Sciences, Hugh Sinclair Unit of Human Nutrition, University of Reading, Reading, UK
2 Institute for Cardiovascular and Metabolic Research (ICMR), University of Reading, Reading, UK
3 Nutritional Genomics Research Group, Faculty of Nutrition, Federal University of Goiás (UFG), Goiania, Goiás, Brazil
4 Department of Food and Nutritional Sciences, Hugh Sinclair Unit of Human Nutrition, University of Reading, Reading, UK; Faculty of Pharmaceutical Sciences, University of Sao Paulo (USP), São Paulo, São Paulo, Brazil
|Date of Web Publication||27-Aug-2019|
Maria A Horst
Nutritional Genomics Research Group, Faculty of Nutrition, Federal University of Goiás, Goiânia, Goiás.
Dr. Vimaleswaran Karani Santhanakrishnan
Department of Food and Nutritional Sciences, Hugh Sinclair Unit of Human Nutrition, University of Reading, Reading.
Source of Support: None, Conflict of Interest: None
Background: Several single-nucleotide polymorphisms (SNPs) have been associated with the metabolism of Vitamin B12, folic acid, homocysteine and lipids. However, the interaction between SNPs involved in the one-carbon metabolism pathway and macronutrient intake on cardiovascular risk factors in the Brazilian population has not yet been investigated. Hence, the present study examined whether the association of ten SNPs involved in the one-carbon metabolism pathway with Vitamin B12, folic acid, homocysteine and lipid levels is modified by dietary factors and physical activity in adolescents with cardiovascular risk. Materials and Methods: A total of 113 adolescents (10–19 years old), from a public school in the city of Goiânia, Goiás, Brazil, underwent anthropometric, biochemical and food consumption evaluations and genetic tests. Results: After adjusting for potential confounders, SNPs rs4633 (catechol-O-methyltransferase, COMT), rs602662 (fucosyltransferase 2, FUT2) and rs1801394 (5-methyltetrahydrofolate-homocysteine methyltransferase reductase) showed significant associations with folic acid (P = 0.042), Vitamin B12 (P = 0.009) and oxidised low-density lipoprotein (ox-LDL) (P = 0.041) concentrations, respectively. The COMT SNP rs4680 showed a significant interaction with carbohydrate intake on ox-LDL concentrations (Pinteraction = 0.005). In addition, the FUT2 SNP rs602662 showed a significant interaction with protein intake on homocysteine concentrations (Pinteraction = 0.007). However, after correction for multiple testing, none of these associations and interactions were statistically significant. Conclusions: For the first time, we provide evidence for the interactions between COMT SNP rs4680 and carbohydrate intake on ox-LDL levels and the FUT2 SNP rs602662 and protein intake on homocysteine concentrations. However, replication of our results in a larger sample size is required to confirm our findings.
Keywords: Brazilian adolescents, carbohydrate, cardiovascular disease, hyperhomocysteinaemia, nutrigenetics, oxidised low-density lipoprotein
|How to cite this article:|
Surendran S, Morais CC, Abdalla DS, Shatwan IA, Lovegrove JA, Cominetti C, Santhanakrishnan VK, Horst MA. The influence of one-carbon metabolism gene polymorphisms and gene-environment interactions on homocysteine, Vitamin B12, folate and lipids in a Brazilian adolescent population. J Diabetol 2019;10:110-22
|How to cite this URL:|
Surendran S, Morais CC, Abdalla DS, Shatwan IA, Lovegrove JA, Cominetti C, Santhanakrishnan VK, Horst MA. The influence of one-carbon metabolism gene polymorphisms and gene-environment interactions on homocysteine, Vitamin B12, folate and lipids in a Brazilian adolescent population. J Diabetol [serial online] 2019 [cited 2019 Nov 18];10:110-22. Available from: http://www.journalofdiabetology.org/text.asp?2019/10/3/110/265413
| Introduction|| |
Cardiovascular disease (CVD) has remained the leading cause of mortality in Brazil since the latter part of the 1960s., Although effective tobacco control policies and access to improved healthcare have led to drastic improvements in cardiovascular health, an upwards trend in unhealthy eating habits and physical inactivity has been observed in the Brazilian population. Smoking, obesity, hypertension, hyperlipidaemia and insulin resistance have long been recognised as major risk factors for CVDs; however, the aetiology of CVD is not yet fully understood. There has recently been renewed interest in the relationship between elevated homocysteine levels and the development of CVD.
Epidemiological studies have shown that hyperhomocysteinaemia is a well-known independent risk factor for atherosclerotic vascular disease and hypercoagulability states. It is known to mediate adverse effects on vascular endothelium and smooth muscle cells. In addition, hyperhomocysteinaemia reduces high-density lipoprotein (HDL) synthesis and enhances the synthesis of lipoprotein A. Some studies have indicated that up to 25% of coronary events may be attributed to the increase in homocysteine levels, which have been shown to inversely correlate with B-complex vitamins, such as folate and Vitamin B12. Although B vitamins have a role in reducing blood homocysteine concentrations, the effect of these vitamins on cardiovascular function remains unclear. A few studies have indicated that high folate and Vitamin B12 status are associated with a reduced risk of coronary heart disease., Therefore, maintaining the concentrations of homocysteine, Vitamin B12, folate and lipids within the body is of grave importance.
The one-carbon metabolism pathway is a network of biochemical reactions involved in the transfer of single-carbon units (CH3 or methyl group), controlled by different enzymes and nutritional cofactors. Cells require one-carbon units for nucleotide synthesis and methylation reactions. At present, common variants in genes of the one-carbon metabolism pathway have been reported to influence the concentrations of homocysteine, folate, Vitamin B12 and lipids. A few studies have examined whether the association between genetic variants involved in the one-carbon metabolism pathway and homocysteine concentrations is modified by lifestyle factors such as diet., However, no studies, to date, have examined the interaction between one-carbon metabolism-related genes and lifestyle factors on Vitamin B12, folate and lipid concentrations. Hence, seven genes involved in the one-carbon metabolism were selected for our study (betaine-homocysteine S-methyltransferase [BHMT], catechol-O-methyltransferase [COMT], fucosyltransferase 2 [FUT2], methylenetetrahydrofolate reductase [MTHFR], 5-methyltetrahydrofolate-homocysteine methyltransferase or methionine synthase [MTR], 5-methyltetrahydrofolate-homocysteine methyltransferase reductase or methionine synthase reductase [MTRR] and transcobalamin 2 [TCN2]).
The aims of the present study were to determine whether ten single-nucleotide polymorphisms (SNPs) from seven selected candidate genes related to the one-carbon metabolism cycle were associated with Vitamin B12, homocysteine, folic acid and lipid-related outcomes and whether these associations were modified by environmental factors (diet and physical activity). Interaction and association analyses were carried out in 113 adolescents with cardiovascular risk factors from the city of Goiânia, Goiás, Brazil.
| Materials and Methods|| |
This cross-sectional study was conducted in a public school in the city of Goiânia, Goiás, Brazil, between March and May 2014. A total of 454 students were initially enrolled into the study, and 201 students were found to be eligible for participation. After screening through lifestyle, socioeconomic and clinical history, only 113 adolescents (aged 10–19 years) were selected to answer a food frequency record and provided a blood sample for biochemical and DNA analyses. Full details of the methodology have been explained previously.[Table 1] shows the characteristics of the study participants.
|Table 1: The characteristics of the study participants stratified by sex|
Click here to view
Participants were selected on the basis that they were overweight/obese and/or were previously diagnosed with dyslipidaemia, but not with CVD. The presence of dyslipidaemia was identified by the use of specific medications or when the interviewees reported having hypercholesterolaemia or hypertriglyceridemia, previously diagnosed by a physician. Individuals were not included in the study if they were previously diagnosed with CVD, they used lipid-lowering drugs and they were supplemented with folic acid, cobalamin and/or pyridoxine and/or nutritional treatment.
The present study was approved by the Federal University of Goiás (addendum in protocol number 422.329, 07/10/2013). Informed consent was obtained from all the study participants, and participants were allowed to leave the study at will and opt out from any of the procedures. Written informed consent was obtained from the study participants whose age was above 18 years and, for those whose age was <18 years, consent was obtained from their parents or guardians. All clinical investigations were conducted according to the principles expressed in the Declaration of Helsinki.
Anthropometric and biochemical measurements
Details of anthropometric measurements have been described previously. In brief, at baseline, all participants were measured for weight, height and waist circumference using standard study protocols. Body mass index (BMI) was estimated as weight (in kg) divided by the square of body height (m). BMI was classified according to the WHO (2007) classification for BMI/age according to sex. Individuals below the 15th percentile were considered below normal weight, those between the 15th and 85th percentiles were classified as normal weight, those who fit between the 85th and 97th percentiles were classified as overweight and those above the 97th percentile were considered obese.
For the determination of biochemical parameters, blood samples (12ml) were collected by peripheral venous puncture in the morning, after a 12-h fast. The blood samples were used to measure homocysteine, Vitamin B12, folic acid, lipid profile (including oxidised low-density lipoprotein [ox-LDL]) concentrations and for DNA extraction. Vitamin B12 and homocysteine concentrations were analysed using a chemiluminescence method. HDL-cholesterol (HDL-C) was determined after precipitation of the LDL and very-LDL (VLDL) fractions. The Friedewald formula was applied to obtain the measurement of LDL and VLDL cholesterol. Plasma ox-LDL levels were measured using commercially available sandwich enzyme-linked immunosorbent assay (Mercodia AB, Uppsala, Sweden).
Assessment of dietary intake and physical activity
The study participants undertook a food consumption record by trained research staff. This method was used to collect participant’s usual food intake, highlighting household measures and portion sizes. All information provided by the participants was double checked for accuracy. Energy and nutrient intake from the recorded data were calculated based on the Avanutri® software (Avanutri Informática Ltda, Rio de Janeiro, Brazil), with emphasis on lipids, Vitamin B12 and folic acid. Wherever appropriate, nutrient intake values were adjusted to energy by the nutrient (energy adjusted) residual method.
The Global Physical Activity Questionnaire, short form, was used to assess physical activity. Individuals were divided into physically active and inactive individuals.
Single-nucleotide polymorphism selection and genotyping
The following ten common SNPs involved in the one-carbon metabolism pathway were selected based on the published reports:,,,,, rs1801133 (677C>T) and rs1801131 (1298A>C) of MTHFR; rs1805087 (2756A>G) of MTR; rs1801394 (66A>G) of MTRR; rs1801198 (776G>C) of TCN2; rs4680 (158G>A) and rs4633 of COMT; rs3797546 and rs492842 of BHMT and rs602662 of FUT2. COMT rs4633,MTHFR rs1801133 and MTHFR rs1801131 SNPs,,, are essential variants known to influence circulating homocysteine. While variations in the BHMT gene may contribute to hyperhomocysteinaemia, it is unknown whether the SNPs rs3797546 and rs492842 alter homocysteine levels. Previous studies indicate that the SNPs MTR rs1805087, MTRR rs1801394,MTHFR rs1801133 and MTHFR rs1801131,,, are associated with folate concentrations. Furthermore, genome-wide significant associations with serum B12 have been reported for the SNPs TCN2 rs1801198 and FUT2 rs602662., The most commonly studied, MTHFR SNP rs1801133, has shown associations with total cholesterol, HDL-C and LDL-cholesterol (LDL-C)., Finally, the COMT rs4680 SNP was found to be associated with triacylglycerol (TAG),, total cholesterol and LDL-C levels.
DNA was then extracted from peripheral leucocytes in the blood, using a commercial kit (Roche™ Diagnostics GmbH, Mannheim, Germany) following the manufacturer’s guidelines accordingly. The purity and concentration of the DNA samples were assessed using a NanoDrop® ND-1000 spectrophotometer (Thermo Scientific, Wilmington, NC, USA). The ten SNPs involved in the one-carbon metabolism were genotyped using real-time polymerase chain reaction using the QuantStudio™ OpenArray TaqMan™ platform (Life Technologies, Foster City, CA, USA) with personalised cards for 12K Flex system QuantStudio® (Life Technologies) with validated TaqMan Assay. The frequency of each SNP in this study sample was in agreement with the Hardy–Weinberg equilibrium (P > 0.05) [Table 2]. All analyses were performed by an experienced laboratory technician who was blinded to the details of the study participants.
|Table 2: Genotype distribution of single-nucleotide polymorphisms involved in the one carbon-metabolism pathway|
Click here to view
Statistical analyses were carried out using the SPSS software (version 22; SPSS Inc., Chicago, IL, USA). Data distribution was verified by the Shapiro–Wilk test. Individuals with BMI of ≥25kg/m2 were categorised as obese and those with a BMI of <25kg/m2 were classified as non-obese. Descriptive statistics for continuous variables were shown as means and standard deviation (SD). The mean differences between continuous variables and the genotypes were analysed by the independent sample t-test.
Linear regression was used to examine the association of the SNPs involved in the one-carbon metabolism pathway with Vitamin B12, folic acid, homocysteine and lipid concentrations (TAG, HDL-C, LDL-C and ox-LDL). The interaction between the SNPs and dietary factors on determining Vitamin B12, folic acid, homocysteine and lipid concentrations was determined by including the interaction term (SNP * diet) in the general linear regression models. Models were adjusted for age, sex, BMI and total energy intake, wherever appropriate. The dominant model was applied only for those SNPs which had a frequency of rare homozygotes ≤19%. Correction for multiple testing was applied using Bonferroni correction (adjusted P value for association was <0.00071 [10 SNPs *7 outcomes (B12, folic acid, homocysteine, TAG, HDL-C, LDL-C and ox-LDL concentrations) = 70 tests]) and for interaction <0.00018 (10 SNPs *7 outcomes [B12, folic acid, homocysteine, TAG, HDL-C, LDL-C and ox-LDL concentrations] *4 lifestyle factors = 280 tests). All data were expressed as mean ± SD.
Given that there were no previously reported effect sizes, we were unable to perform a power calculation. However, based on the effect sizes that were observed for the associations, we performed a retrospective power calculation using the Quanto software, version 1.2.4 (May 2009, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 2001N Soto Street, Los Angeles, CA 90032). Power calculations were carried out in the form of least detectable effects based on the assumption of significance levels and powers of 5% and 80%, respectively. At 80% power, the minimum detectable effects ranged from beta 7.5 U/L (ox-LDL) for a SNP with minor allele frequency (MAF) of 15% to beta 8.5 U/L for a SNP with MAF 50% for a sample size of 113 individuals.
| Results|| |
Characteristics of the participants
The clinical characteristics of the studied population are shown in [Table 1]. The sample consisted of 47 boys and 66 girls. The mean age ± SD of the student group was 13.32 ± 2.35 years for boys and 14.26 ± 2.32 years for girls. When the metabolite means were categorised by sex, plasma homocysteine and HDL concentrations were found to show significant differences between boys and girls (P = 0.009 and P = 0.040, respectively). In the study population, dietary intake of carbohydrate (energy %) and protein intake (energy %) were higher in girls than boys (P = 0.003 and P = 0.006, respectively), while there was no significant difference observed (P = 0.087) in dietary intake of fat (energy %) between girls and boys [Table 1].
Association between single-nucleotide polymorphisms and Vitamin B12, folic acid, homocysteine and lipid traits
When analysing associations between ten SNPs involved in genes related to the one-carbon metabolism cycle and biochemical indexes, we found that COMT rs4633 was significantly associated with folic acid (Passociation = 0.042). Folic acid was significantly lower in CC common homozygous individuals (10.25 ± 2.99ng/ml) than in pooled TT and CC individuals (11.67 ± 3.29ng/ml) (Passociation = 0.042) [Table 3]. Furthermore, homozygosity for the G allele at the FUT2 rs602662 SNP was significantly associated with lower Vitamin B12 concentrations compared with the wild-type group where Vitamin B12 concentrations were 24.27% lower in GG individuals than in AA individuals (Passociation = 0.009) [Table 3]. In addition to these findings, the minor allele (G) of the MTRR rs1801394 SNP was significantly associated with elevated ox-LDL levels (Passociation = 0.041) [Table 3]. After Bonferroni correction, none of the results were considered statistically significant (P > 0.00071).
|Table 3: Association between single-nucleotide polymorphisms involved in the one-carbon metabolism pathway and Vitamin B12, homocysteine, folic acid and lipid traits|
Click here to view
Interaction between single-nucleotide polymorphisms and Vitamin B12, folic acid and homocysteine
An interaction was observed between the BHMT SNP rs492842 and dietary fat intake on Vitamin B12 levels (P = 0.034). In addition, further interactions were found between the FUT2 SNP rs602662 with dietary protein intake (P = 0.007) and carbohydrate intake (P = 0.031) on homocysteine concentrations [Table 4]. We found that rare AA homozygotes of the FUT2 SNP rs602662 had higher homocysteine levels (mean ± standard error [SE]: 8.038 ± 0.896 μmol/L) compared to the GG allele carriers (mean ± SE: 5.857 ± 1.039 μmol/L) among those in the highest tertile of protein intake (mean ± SE: 148.618 ± 5.777g/day); however, the difference in the means of homocysteine concentrations between the genotype groups in the highest tertile of protein intake was not statistically significant (P = 0.227), which could be because of the small sample size.
|Table 4: Interaction between single-nucleotide polymorphisms and dietary factors on Vitamin B12, homocysteine and folic acid traits|
Click here to view
Interaction between single-nucleotide polymorphisms and dietary factors on lipid concentrations
Interactions were observed between the COMT SNPs (rs4680 and rs4633) and dietary carbohydrate intake on HDL-C concentrations (P = 0.011 and P = 0.036, respectively). Furthermore, an interaction was found between the COMT SNP (rs4680) and dietary carbohydrate intake on ox-LDL concentrations (P = 0.005) [Table 5]. However, none of the interactions between the SNPs and dietary intake on lipid outcomes reached statistical significance after correction for multiple testing.
|Table 5: Interaction between single-nucleotide polymorphisms and dietary factors on lipid traits|
Click here to view
Gene–physical activity interactions on Vitamin B12, folic acid, homocysteine and lipid profile
No statistically significant interactions were observed after correction for multiple testing between the ten SNPs and physical activity on Vitamin B12, folic acid, homocysteine and lipid traits (Pinteraction > 0.00018) [Supplementary Table 1].
|Supplementary Table 1: P values for the interaction between single-nucleotide polymorphisms and physical activity levels on Vitamin B12, homocysteine, folic acid and lipid traits|
Click here to view
| Discussion|| |
To our knowledge, this is the first genetic epidemiological study to investigate the interactions between SNPs involved in the one-carbon metabolism pathway and environmental/lifestyle factors on Vitamin B12, folic acid, homocysteine and lipid levels (HDL-C, LDL, TAG and ox-LDL) in the Brazilian adolescent population. Our study provides evidence for novel interactions between SNP rs4680 (COMT gene) and carbohydrate intake on ox-LDL levels and the SNP rs602662 (FUT2 gene) and protein intake on homocysteine concentrations in Brazilian adolescents. Given that ox-LDL and hyperhomocysteinaemia are well-known independent risk factors for atherosclerotic vascular disease,, our findings have significant public health implications.
Genes involved in one-carbon metabolism are of particular interest because of their role in CVDs. From the ten SNPs which were investigated in this study, association of the SNP rs4633 at the COMT gene with folic acid concentrations (P = 0.042), the SNP rs602662 at the FUT2 gene with Vitamin B12 levels (P = 0.009) and finally the SNP rs1801394 at the MTRR gene with ox-LDL concentrations (P = 0.041) was observed. Even though the findings were not significant after Bonferroni correction, the association between the FUT2 SNP rs602662 and Vitamin B12 concentrations is in accordance with previous studies.,,,,,, Since the current sample size is relatively small, further studies utilising a larger sample size are required to confirm the observed associations.
To date, only one study has shown a gene–diet interaction on ox-LDL concentrations in a population from the Attica region in Greece. In this study, there was an interaction of the MTHFR SNP rs1801133 with the Mediterranean diet on ox-LDL concentrations. A high adherence to the Mediterranean diet was found to be associated with decreased ox-LDL concentrations in T allele carriers of SNP rs1801133. Further to this, many studies have reported that MTHFR variants (C677T and A1298C) are linked to higher homocysteine levels when folate consumption is low., In the present study, we identified significant gene–diet interactions between SNP rs4680 at the COMT gene and carbohydrate intake on ox-LDL concentrations and the SNP rs602662 at the FUT2 gene and protein intake on homocysteine concentrations. However, further stratification of participants based on their consumption of low-, medium- and high-dietary carbohydrate/protein did not show a statistically significant association between the SNP and the outcome in any of the tertiles, which could account for the small sample size. This is the first study to provide evidence for gene–diet interactions at the COMT and FUT2 gene loci, on ox-LDL and homocysteine concentrations, respectively, and hence, we do not have any previous studies to compare our findings.
Total carbohydrate intake has increased considerably in Brazil in the last few decades. Data from two population-based surveys conducted in women over 35 years of age from Rio de Janeiro reported that the carbohydrate intake has increased from 352g (95% confidence interval [CI]: 325–382) in 1995 to 437g (95% CI: 415–458) in 2005. Interestingly, our study in this Brazilian adolescent population has identified an interaction between COMT SNP rs4680 and carbohydrate intake on ox-LDL concentrations. Despite our study being the first to report this gene–diet interaction, previous studies have shown that carbohydrate-restricted diets can promote weight loss and are associated with reduced CVD risk. However, the exact mechanism by which the COMT SNP rs4680 interacts with dietary carbohydrate to influence ox-LDL concentrations is unknown, which requires further studies to understand the mechanism contributing to this association. Furthermore, in our study, we observed an interaction of the FUT2 SNP rs1805087 with protein consumption on homocysteine levels. However, we have no previous studies to confirm and validate this novel finding. The findings in this article suggest that the inheritance of ox-LDL and homocysteine levels is complex, where several genes/polymorphisms are likely to contribute to the alteration of ox-LDL or homocysteine levels through gene–gene and gene–diet interactions. More in-depth research implementing animal studies, nutrigenomics and metabolomics are needed to clarify the effects of SNPs and carbohydrate on ox-LDL concentrations and protein on homocysteine concentrations, respectively.
One of the main limitations of our study is the small sample size. Given that there are no previously reported effect sizes for the FUT2 and COMT SNP–diet interactions on blood homocysteine and ox-LDL concentrations, we were unable to calculate the statistical power of our study. Our retrospective power calculation showed that the minimum detectable effects for ox-LDL levels ranged from beta 7.5 U/L (ox-LDL) for a SNP with MAF of 15% to beta 8.5 U/L for a SNP with MAF 50%. Hence, if the actual effect sizes were lower than this, our study would be underpowered. However, our study did find significant associations and gene–diet interactions despite the small sample size, but the findings require a replication given that the significant P values did not reach the Bonferroni-corrected P value. Another limitation is that our study was of cross sectional design, and therefore, we were unable to examine the causal relationship between the SNP–diet interactions on blood homocysteine and ox-LDL concentrations. Therefore, randomised controlled trials with prospective genotyping are required to explore the causality using genetic markers. Given that our study relied on a usual food record, we cannot negate the possibility of misreporting and measurement error. On the other hand, the main strength of our study is that we examined the effect of ten SNPs on Vitamin B12, folic acid, homocysteine concentrations and lipid traits during adolescence, a critical period where lifestyle habits are usually followed through to adulthood. By studying this population, we were able to identify different genotypes of interest, which could be further investigated to improve the understanding of the role of these micronutrients in relation to the prevention of hyperhomocysteinaemia and increased ox-LDL concentrations. In addition, little is known about gene–diet interactions which influence ox-LDL concentrations, and thus our study adds to the limited body of research.
| Conclusions|| |
Our study shows an interaction between COMT SNP rs4680 and carbohydrate intake on ox-LDL levels among adolescents with cardiovascular risk factors. Furthermore, a borderline interaction was observed between FUT2 SNP rs602662 and protein intake on homocysteine concentrations. After correction for multiple testing, none of the SNP–environment interactions on homocysteine, folate, Vitamin B12 or lipid concentrations were detected. Hence, our findings warrant confirmation in larger, well-characterised and well-powered prospective studies/randomised controlled trials, before any public health recommendations and personalised nutrition advice can be developed for the adolescent Brazilian population.
The authors would like to thank Fundação de Amparo à Pesquisa do Estado de Goiás (FAPEG) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) for financial support and Centro de Genomas® (São Paulo, Brazil) for undertaking the genotyping analysis.
Financial support and sponsorship
Fundação de Amparo à Pesquisa do Estado de Goiás (FAPEG) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) offered financial support for the study.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Schmidt MI, Duncan BB, Azevedo e Silva G, Menezes AM, Monteiro CA, Barreto SM, et al
. Chronic non-communicable diseases in Brazil: Burden and current challenges. Lancet 2011;377:1949-61.
Ribeiro AL, Duncan BB, Brant LC, Lotufo PA, Mill JG, Barreto SM, et al
. Cardiovascular health in Brazil: Trends and perspectives. Circulation 2016;133:422-33.
Qazi MU, Malik S. Diabetes and cardiovascular disease: Original insights from the Framingham Heart Study. Glob Heart 2013;8:43-8.
Garcia G, Trejos J, Restrepo B, Landázuri P. Homocysteine, folate and Vitamin B12 in Colombian patients with coronary disease. Arq Bras Cardiol 2007;89:71-6, 79-85.
Shenoy V, Mehendale V, Prabhu K, Shetty R, Rao P. Correlation of serum homocysteine levels with the severity of coronary artery disease. Indian J Clin Biochem 2014;29:339-44.
Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J 2015;14:6.
Liao D, Yang X, Wang H. Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease. Clin Chem Lab Med 2007;45:1652-9.
de Luis DA, Fernandez N, Arranz ML, Aller R, Izaola O, Romero E, et al
. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2. J Diabetes Complications 2005;19:42-6.
Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, et al
. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Z Kardiol 2004;93:439-53.
Narang M, Singh M, Dange S. Serum homocysteine, Vitamin B12 and folic acid levels in patients with metabolic syndrome. J Assoc Physicians India 2016;64:22-6.
Ishihara J, Iso H, Inoue M, Iwasaki M, Okada K, Kita Y, et al
. Intake of folate, Vitamin B6 and Vitamin B12 and the risk of CHD: The Japan public health center-based prospective study cohort I. J Am Coll Nutr 2008;27:127-36.
Voutilainen S, Rissanen TH, Virtanen J, Lakka TA, Salonen JT; Kuopio Ischemic Heart Disease Risk Factor Study, et al
. Low dietary folate intake is associated with an excess incidence of acute coronary events: The Kuopio Ischemic Heart Disease risk factor study. Circulation 2001;103:2674-80.
Selhub J. Folate, Vitamin B12 and Vitamin B6 and one carbon metabolism. J Nutr Health Aging 2002;6:39-42.
Hazra A, Kraft P, Lazarus R, Chen C, Chanock SJ, Jacques P, et al
. Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway. Hum Mol Genet 2009;18:4677-87.
Dedoussis GV, Panagiotakos DB, Chrysohoou C, Pitsavos C, Zampelas A, Choumerianou D, et al
. Effect of interaction between adherence to a Mediterranean diet and the methylenetetrahydrofolate reductase 677C--> T mutation on homocysteine concentrations in healthy adults: The ATTICA study. Am J Clin Nutr 2004;80:849-54.
Steluti J, Carvalho AM, Carioca AA, Miranda A, Gattás GJ, Fisberg RM, et al
. Genetic variants involved in one-carbon metabolism: Polymorphism frequencies and differences in homocysteine concentrations in the folic acid fortification era. Nutrients 2017;9. pii: E539.
Morais CC, Alves MC, Augusto EM, Abdalla DS, Horst MA, Cominetti C, et al
. The MTHFR C677T polymorphism is related to plasma concentration of oxidized low-density lipoprotein in adolescents with cardiovascular risk factors. J Nutrigenet Nutrigenomics 2015;8:105-13.
de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J, et al
. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 2007;85:660-7.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
Santo Faulin Tdo E, de Sena KC, Rodrigues Telles AE, de Mattos Grosso D, Bernardi Faulin EJ, Parra Abdalla DS, et al
. Validation of a novel ELISA for measurement of electronegative low-density lipoprotein. Clin Chem Lab Med 2008;46:1769-75.
Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997;65:1220S-8S.
Tanaka T, Scheet P, Giusti B, Bandinelli S, Piras MG, Usala G, et al
. Genome-wide association study of Vitamin B6, Vitamin B12, folate, and homocysteine blood concentrations. Am J Hum Genet 2009;84:477-82.
Oussalah A, Levy J, Filhine-Trésarrieu P, Namour F, Guéant JL. Association of TCN2 rs1801198 c. 776G>C polymorphism with markers of one-carbon metabolism and related diseases: A systematic review and meta-analysis of genetic association studies. Am J Clin Nutr 2017;106:1142-56.
Matteini AM, Walston JD, Bandeen-Roche K, Arking DE, Allen RH, Fried LP, et al
. Transcobalamin-II variants, decreased Vitamin B12 availability and increased risk of frailty. J Nutr Health Aging 2010;14:73-7.
Singh PR, Lele SS. Folate gene polymorphisms MTR A2756G, MTRR A66G, and BHMT G742A and risk for coronary artery disease: A meta-analysis. Genet Test Mol Biomarkers 2012;16:471-5.
Feng Q, Kalari K, Fridley BL, Jenkins G, Ji Y, Abo R, et al
. Betaine-homocysteine methyltransferase: Human liver genotype-phenotype correlation. Mol Genet Metab 2011;102:126-33.
Papageorgiou N, Tousoulis D. Oxidized-LDL immunization for the treatment of atherosclerosis: How far are we? Int J Cardiol 2016;222:93-4.
Husemoen LL, Skaaby T, Thuesen BH, Grarup N, Sandholt CH, Hansen T, et al
. Mendelian randomisation study of the associations of Vitamin B12 and folate genetic risk scores with blood pressure and fasting serum lipid levels in three Danish population-based studies. Eur J Clin Nutr 2016;70:613-9.
Tanwar VS, Chand MP, Kumar J, Garg G, Seth S, Karthikeyan G, et al
. Common variant in FUT2 gene is associated with levels of Vitamin B(12) in Indian population. Gene 2013;515:224-8.
Nongmaithem SS, Joglekar CV, Krishnaveni GV, Sahariah SA, Ahmad M, Ramachandran S, et al
. GWAS identifies population-specific new regulatory variants in FUT6 associated with plasma B12 concentrations in Indians. Hum Mol Genet 2017;26:2551-64.
Zinck JW, de Groh M, MacFarlane AJ. Genetic modifiers of folate, Vitamin B-12, and homocysteine status in a cross-sectional study of the Canadian population. Am J Clin Nutr 2015;101:1295-304.
Grarup N, Sulem P, Sandholt CH, Thorleifsson G, Ahluwalia TS, Steinthorsdottir V, et al
. Genetic architecture of Vitamin B12 and folate levels uncovered applying deeply sequenced large datasets. PLoS Genet 2013;9:e1003530.
Hazra A, Kraft P, Selhub J, Giovannucci EL, Thomas G, Hoover RN, et al
. Common variants of FUT2 are associated with plasma Vitamin B12 levels. Nat Genet 2008;40:1160-2.
Pitsavos C, Panagiotakos D, Trichopoulou A, Chrysohoou C, Dedoussis G, Chloptsios Y, et al
. Interaction between Mediterranean diet and methylenetetrahydrofolate reductase C677T mutation on oxidized low density lipoprotein concentrations: The ATTICA study. Nutr Metab Cardiovasc Dis 2006;16:91-9.
Homocysteine Lowering Trialists' Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: A meta-analysis of the randomized trials. Am J Clin Nutr 2005;82:806-12.
Ashfield-Watt PA, Pullin CH, Whiting JM, Clark ZE, Moat SJ, Newcombe RG, et al
. Methylenetetrahydrofolate reductase 677C--> T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: A randomized controlled trial. Am J Clin Nutr 2002;76:180-6.
de Andrade RG, Pereira RA, Sichieri R. Ten-year increase in the prevalence of obesity and reduction in fat intake in Brazilian women aged 35 years and older. J Epidemiol Community Health 2010;64:252-4.
Volek JS, Sharman MJ, Forsythe CE. Modification of lipoproteins by very low-carbohydrate diets. J Nutr 2005;135:1339-42.
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Supplementary Table 1]